-transparent.png){kind=logo}
The dopaminergic agonist Bromocriptine has been perfused in vivo in normal Wistar rats to control its activity on Glucose-3-H3 metabolism. Bromocriptine shows a rapid influence on glucose production rate (Ra) and glucose utilization rate (Rd). Both rates increase, but since Bromocriptine effects on glucose production rate is more significant than the ones on glucose utilization, the final results is an increase in plasma glucose levels. Since glucose production rate in normal animals is practically equal to hepatic glucose output, the most logical explantation of Bromocriptine activity is the activation of glycogenosis with a rise of plasma glucose levels.
Related Publications
M G Piccardo, and
L Russo, and
M Rosa
January 1966,
Advances in tracer methodology,
M G Piccardo, and
L Russo, and
M Rosa
October 1978,
Bollettino della Societa italiana di biologia sperimentale,
M G Piccardo, and
L Russo, and
M Rosa
January 1977,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
M G Piccardo, and
L Russo, and
M Rosa
October 1978,
Bollettino della Societa italiana di biologia sperimentale,
M G Piccardo, and
L Russo, and
M Rosa
July 1990,
The Journal of biological chemistry,
M G Piccardo, and
L Russo, and
M Rosa
January 1968,
Acta vitaminologica et enzymologica,
M G Piccardo, and
L Russo, and
M Rosa
April 1981,
Canadian journal of biochemistry,
M G Piccardo, and
L Russo, and
M Rosa
January 1990,
Hormone and metabolic research. Supplement series,
M G Piccardo, and
L Russo, and
M Rosa
October 1993,
Bailliere's clinical endocrinology and metabolism,
M G Piccardo, and
L Russo, and
M Rosa
July 1953,
Metabolism: clinical and experimental,
